1. Home
  2. NSRX vs CLNN Comparison

NSRX vs CLNN Comparison

Compare NSRX & CLNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NSRX
  • CLNN
  • Stock Information
  • Founded
  • NSRX 2019
  • CLNN 2012
  • Country
  • NSRX Israel
  • CLNN United States
  • Employees
  • NSRX N/A
  • CLNN N/A
  • Industry
  • NSRX Biotechnology: Pharmaceutical Preparations
  • CLNN Biotechnology: Pharmaceutical Preparations
  • Sector
  • NSRX Health Care
  • CLNN Health Care
  • Exchange
  • NSRX Nasdaq
  • CLNN Nasdaq
  • Market Cap
  • NSRX 73.0M
  • CLNN 60.3M
  • IPO Year
  • NSRX 2025
  • CLNN N/A
  • Fundamental
  • Price
  • NSRX $7.60
  • CLNN $8.85
  • Analyst Decision
  • NSRX Strong Buy
  • CLNN Strong Buy
  • Analyst Count
  • NSRX 1
  • CLNN 6
  • Target Price
  • NSRX $22.00
  • CLNN $32.67
  • AVG Volume (30 Days)
  • NSRX 5.5K
  • CLNN 152.6K
  • Earning Date
  • NSRX 11-20-2025
  • CLNN 11-12-2025
  • Dividend Yield
  • NSRX N/A
  • CLNN N/A
  • EPS Growth
  • NSRX N/A
  • CLNN N/A
  • EPS
  • NSRX N/A
  • CLNN N/A
  • Revenue
  • NSRX N/A
  • CLNN $286,000.00
  • Revenue This Year
  • NSRX N/A
  • CLNN N/A
  • Revenue Next Year
  • NSRX N/A
  • CLNN $1,363.77
  • P/E Ratio
  • NSRX N/A
  • CLNN N/A
  • Revenue Growth
  • NSRX N/A
  • CLNN N/A
  • 52 Week Low
  • NSRX $5.90
  • CLNN $2.28
  • 52 Week High
  • NSRX $9.99
  • CLNN $11.06
  • Technical
  • Relative Strength Index (RSI)
  • NSRX N/A
  • CLNN 56.73
  • Support Level
  • NSRX N/A
  • CLNN $7.66
  • Resistance Level
  • NSRX N/A
  • CLNN $9.77
  • Average True Range (ATR)
  • NSRX 0.00
  • CLNN 0.85
  • MACD
  • NSRX 0.00
  • CLNN -0.07
  • Stochastic Oscillator
  • NSRX 0.00
  • CLNN 56.60

About CLNN Clene Inc.

Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.

Share on Social Networks: